Humedix Co Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: 0.019x

Humedix Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Humedix Co Ltd (200670) has a cash flow conversion efficiency ratio of 0.019x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩5.71 Billion ≈ $3.87 Million USD) by net assets (₩308.15 Billion ≈ $208.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Humedix Co Ltd (2015–2025)

Cash flow conversion efficiency of Humedix Co Ltd from 2015 to 2025. This chart illustrates how Humedix Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Humedix Co Ltd (200670) stock price for real-time trading data and today's change.

Humedix Co Ltd Cash Flow Conversion Ratio Explained

Humedix Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Humedix Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Humedix Co Ltd ranked by their cash flow conversion efficiency. Also see Humedix Co Ltd (200670) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Betmakers Technology Group Ltd AU:BET	0.053x
Tele2 AB (publ) ST:TEL2-A	0.118x
Radcom Ltd NASDAQ:RDCM	0.022x
TrueBlue Inc NYSE:TBI	-0.038x
City Retail Developments Tbk PT JK:NIRO	0.124x
Shenzhen Dvision Video Communica SHE:300167	-0.220x
Havilah Resources Ltd AU:HAV	-0.017x
Lippo Karawaci Tbk JK:LPKR	-0.016x

Annual Cash Flow Conversion Efficiency for Humedix Co Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of Humedix Co Ltd from 2015 to 2025. Review cash generation quality of Humedix Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩299.59 Billion ≈ $203.03 Million	₩45.15 Billion ≈ $30.59 Million	0.151x	-32.13%
2024-12-31	₩228.53 Billion ≈ $154.87 Million	₩50.74 Billion ≈ $34.39 Million	0.222x	+42.39%
2023-12-31	₩198.06 Billion ≈ $134.22 Million	₩30.89 Billion ≈ $20.93 Million	0.156x	-43.14%
2022-12-31	₩139.11 Billion ≈ $94.27 Million	₩38.15 Billion ≈ $25.86 Million	0.274x	+80.11%
2021-12-31	₩125.99 Billion ≈ $85.38 Million	₩19.18 Billion ≈ $13.00 Million	0.152x	-23.06%
2020-12-31	₩120.07 Billion ≈ $81.37 Million	₩23.76 Billion ≈ $16.10 Million	0.198x	+60.66%
2019-12-31	₩112.10 Billion ≈ $75.97 Million	₩13.81 Billion ≈ $9.36 Million	0.123x	-45.07%
2018-12-31	₩106.13 Billion ≈ $71.93 Million	₩23.80 Billion ≈ $16.13 Million	0.224x	+176.11%
2017-12-31	₩107.92 Billion ≈ $73.13 Million	₩8.77 Billion ≈ $5.94 Million	0.081x	+16.47%
2016-12-31	₩109.11 Billion ≈ $73.94 Million	₩7.61 Billion ≈ $5.16 Million	0.070x	-34.59%
2015-12-31	₩109.80 Billion ≈ $74.41 Million	₩11.71 Billion ≈ $7.93 Million	0.107x	--

About Humedix Co Ltd

KQ:200670 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$170.42 Million

₩251.47 Billion KRW

Market Cap Rank

#16984 Global

#654 in Korea

Share Price

₩22650.00

Change (1 day)

-1.52%

52-Week Range

₩22600.00 - ₩50800.00

All Time High

₩75800.00